This has plagiarism written all over it dude! You haven't had an original thought in your entire life!
I believe that the retail investors have placed stop losses when the stock went up quickly topping at $6.44. The MM's IMHO are now taking out these stop losses only to accumulate more stock only to sell at a higher pps later in the trading day.
Three thumbs up on that presentation done by Dr. Swisher. Very bullish discussion on Vosaroxin and the other drugs in the pipeline. Dr. Swisher all but said that he has exciting news to bring to ASCO and another conference prior to ASCO. There is no wonder the stock is current ly up today gaining back yesterday's pullback.
I am more encouraged than ever! GLTAL
Now I am positive that something big is up!
I will certainly keep that in mind the next time they rant. I appreciate your informing me of their activities.
I love it when a plan comes together. I have my sights on $7 + before the day is over. I'm not sure we will do it today, but it's a possibility.
GLTU and GLTAL
I've been looking at the 6 month chart for SNSS and here is what my thought is for today's action.
MFI (14 days) 63.45 - RSI (14 days) 59.04 - ROC (12 days) .50 PSAR $4.19 rising and the BBands (20,2) Upper limit is $4.97 and the Lower limit is $4.08.
IMHO based on the information I have provided we are ready for a breakout to the upside. Volume will dictate the ferocity of the move and will establish the necessary momentum to go through the resistance levels yet to be crossed.
A 13G was filed by Alta Bio Pharma yesterday for over 6 million shares of stock and about 1 million warrants or so. This was originally filed on a 13D in 2009, and 2010 by the same company. Not sure of the significance of this transaction going from a 13D to a 13G. Maybe someone can shed some lighjt between the two SEC filings.
I expect the stock to move up from this point on. We are way oversold at this point.
IMHO the move will continue to be upward tomorrow. The indications on the chart that I have developed all point to a continued rise. It's now a matter of how much pain the shorts are willing to take before they throw in the proverbial towel. My guess will be in the $6.00 area and that is fine with me.
Sunesis is presenting at the 2014 RBC Capital Markets' Global Healthcare Conference at 1:35 PM ET. This investor conference can be another catalyst for the momentum we have been experiencing. Depends on the mood of the attendees when in the question and answer period.
We are offering shares of our common stock and warrants to purchase up to shares of our common stock (and the shares of common stock
issuable from time to time upon exercise of each of the warrants), pursuant to this prospectus supplement and the accompanying prospectus. The common
stock and warrants will be sold in combination, with two warrants, each to purchase one share of common stock, for each one share of common stock sold.
The purchase price for each share of common stock and accompanying warrants is $ .
Each warrant will be exercisable beginning on the unblinding date described below. One of the warrants will have an exercise price of $8.50 per share and will
expire on the later of 30 calendar days after the unblinding date and December , 2014 (but in any event no later than March , 2016). The other warrant
will have an exercise price of $12.00 per share and will expire on the later of 30 calendar days after the PDUFA date described below (but in any event no later
than March , 2016) and September , 2015.
Our common stock is listed on The NASDAQ Stock Market under the symbol “SNSS”. On February 25, 2014, the last reported sale price of our common
stock was $6.19 per share. There is no established public trading market for the warrants and we do not expect a market to develop. In addition, we do not
intend to apply for listing of the warrants on any securities exchange or recognized trading system. The warrants will be issued in book-entry form pursuant to
a warrant agency agreement between us and American Stock Transfer & Trust Company, as warrant agent.
Beat earnings estimate by .05 cents and beat on revenues by .64 million. They mentioned the abstract in the earnings report and pointed to the AACR website for more information. I believe this will be on the con call and a BIG catalyst for todays trading.
No number of shares or number of warrants were listed in this filing. malph_ralph is nothing more than a FOOL! I would urge all of you to read this 424B5 to get the facts, and not to listen to crackhead malph_ralph.
HE KNOWS NOTHING!
He is absolutely out of his mind and losing a lot of money on this stock ergo the ramblings and bashing.
BINGO! Hopefully he will limit his pain by covering his short positions. IMHO he won't admit that he was wrong 'cause in his mind he's always right!
MM's run the stock up to higher levels early on ($6.50) only to wait for the retail folks to put on their stop losses, and the MM's run the stock down, stopping them out, accumulating their stock at lower prices, only to turn around later in the day to run it up.
Hang in there. It's all good!
Tea leaves, charts, gut feel, whatever method you may use, doesn't matter today. It's all about momentum and shares traded, i.e. volume and lots of it.
I've been waiting a very long time for this ride up. Relax, get a pot of coffee brewing and enjoy!
The 1,116,184 Long- Short Volume (green area) is the difference between the Long number and the short number for the day of Feb. 7, 2014. There were 1,116,184 more long activities. You can verify this number by going to Shortanalytics website.